Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation
Randomized Trial for the Treatment of Recurrent Anterior Dislocation of the Shoulder: Latarjet Versus Modified Eden-Hybinette
1 other identifier
interventional
60
1 country
1
Brief Summary
Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 16, 2016
CompletedFirst Posted
Study publicly available on registry
September 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
January 29, 2026
January 1, 2026
11.3 years
September 16, 2016
January 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Western Ontario Shoulder Instability Index (WOSI)
Instability score
2 years
Secondary Outcomes (13)
ROWE score
2 years
Visual analog scale (VAS) for shoulder pain
2 years
VAS for iliac pain
6 weeks
VAS for iliac pain
3 months
VAS for iliac pain
2 years
- +8 more secondary outcomes
Study Arms (2)
Latarjet procedure
ACTIVE COMPARATOROpen Latarjet-Patte procedure. Surgery. Anterior glenoid bone graft from coracoid. Fixation with 2 screws.
Modified Eden-Hybinette Procedure
EXPERIMENTALSurgery. Modified Eden-Hybinette surgery, with capsular repair on the iliac bone Anterior glenoid bone graft from iliac bone. Fixation with 2 screws.
Interventions
Open anterior glenoid bone graft from iliac bone crest, with capsular suture and screw fixation
Eligibility Criteria
You may qualify if:
- History of one or more previous episodes of traumatic glenohumeral dislocation;
- Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;
- Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;
- Borderline bipolar bone lesions:
- Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than 13.5% of their diameter, measured by the method described by Sugaya et al.;
- Hill-Sachs lesion and glenoid considered "off-track".
You may not qualify if:
- Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);
- Untreated seizures;
- Previously diagnosed rotator cuff complete tear;
- Fractures of the proximal humerus (except for Hill-Sachs lesions);
- Multidirectional instability;
- Advanced glenohumeral osteoarthritis (grade 3 Samilson and Pietro)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulolead
- Faculdade de Medicina de Jundiaícollaborator
Study Sites (1)
Instituto de Ortopedia e Traumatologia
São Paulo, São Paulo, 05403-010, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
September 16, 2016
First Posted
September 23, 2016
Study Start
September 1, 2016
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2029
Last Updated
January 29, 2026
Record last verified: 2026-01